Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Category

1 … 7 8 9

Clinical disease activity status (exacerbation versus quiescence) in subjects with relapsing-remitting multiple sclerosis is accurately classified using multivariate serum protein biomarker models

Research Presented at ECTRIMS 2019 Stockholm, Sweden — September 11-13, 2019

Clinical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Improved detection of clinically relevant MRI findings in Multiple Sclerosis radiology reports using FDA-approved quantitative software

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

From proteome to interactome: a mechanistic approach to MS biomarker discovery

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Cross-sectional and longitudinal estimation of radiographic and clinical endpoints to quantify MS disease trajectory with blood serum protein levels.

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Proteomic Serum Biomarker Signatures Associated with Patient Reported Outcomes in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Integrated Analysis of Novel MRI and Blood Serum Biomarkers for the Estimation and Prediction of MS Disease Activity and Progression

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Development of a Custom Multivariate Proteomic Serum Based Assay for Association with Radiographic and Clinical Endpoints in MS

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Changes in the Detection of Clinically Relevant White Matter Lesions in MS Using FDA-Cleared Automated Software

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Analytical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021